Histamine H1 Blockers: From Relative Failures to Blockbusters within Series of Analogues

Analogue-based Drug Discovery

Volumn , Issue , 2006, Pages 401-418

  Timmerman, Henk ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Analogue based drug discovery; Diphenhydramine; First antihistamines; Histamine H1 blockers; Inverse agonism; New antihistamines

Indexed keywords

EID: 84889823100     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/3527608001.ch21     Document Type: Chapter

References (31)

1. Windaus A, Vogt W. Chem. Ber., 1907, 40, 3691.
2. Dale HH, Laidlaw PP. J. Physiol., 1910, 41, 318.
3. Dale HH, Laidlaw PP. J. Physiol., 1911, 43, 182.
4. Dale HH. Foreword. In: Handbook of Exp. Pharmacol. XVIII-1, Histamine and anti-Histamines. Rocha e Silva M (Ed.) Springer-Verlag, Berlin, 1966.
5. Staub AM. Ann. Inst. Pasteur Paris, 1939, 63, 400, 420, 485.
6. Casy AF. Chemistry and structure-activity relationship of synthetic anti-histamines. In: Histamine and anti-Histaminics. II, Handbook of Experimental Pharmacology. Rocha e Silva M (Ed.). Springer, Berlin, 1978, p. 175.
7. Nauta WTH, Rekker RF. Structure-activity relationships of H1 receptor antagonists. In: Histamine and anti-Histaminics. II, Handbook of Experimental Pharmacology. Rocha a Silva M (Ed.). Springer, Berlin, 1978, p. 215.
8. Harms AF, Hespe W, Nauta WTH, Rekker RF, Timmerman H, Vries J. de. Diphenhydramine derivatives: through manipulation toward design. In: Drug Design. Vol. VI. Ariëns EJ (Ed.). Academic Press, New York, 1975, p. 2.
9. Zhang MQ, Leurs R, Timmerman H. Histamine H1 receptor antagonists. In: Burger's Medicinal Chemistry and Drug Discovery. Wolff ME (Ed.). John Wiley & Sons, 1997.
10. Rekker RF. The predictive merits of antihistamine QSAR studies. In: Strategy in Drug Research. Keverling Buisman JA (Ed.). Elsevier, Amsterdam, 1982, p. 315.
11. Diurno MV, Mazzaroni O, Piscopo E, Calignano F, Bolognese A. J. Med. Chem., 1992, 35, 2910.
12. Wieland K, Ter Laak AM, Smit NJ, Kühne A, Timmerman H, Leurs R. J. Biol. Chem., 1999, 274, 29994.
13. Ebenother A, Weber HP. Helv. Chem. Acta, 1976, 59, 2462.
14. Schoefter P, Ghysel-Burton J, Cabanie M, Godfraind T. Eur. J. Pharmacol., 1987, 139, 235.
15. Awack TT, Duchemin AM, Rise C, Schwartz JC. Eur. J. Pharmacol., 1979, 60, 391.
16. Nicholson AN, Pascoe PA, Turner C, Ganellini CR, Greengrass PN, Casy AF, Mercer AD. Br. J. Pharmacol., 1991, 104, 270.
17. Barbe J, Andrews PR, Lloyd EJ, Browant P, Soyfer JC, Galy JP, Galy AM. Eur. J. Med. Chem., 1983, 18, 1531.
18. Ahn HS, Barett A. Eur. J. Pharmacol., 1986, 127, 153.
19. Ter Laak AM, Donné-Op den Kelder GM, Bast A, Timmerman H. Eur. J. Pharmacol., 1993, 232, 199.
20. ZhangMQ, ter Laak AM, TimmermanH. Biorg. Med. Chem. Lett., 1991, 1, 387.
21. Taglialatela M, Timmerman H, Annunziata L. Trends Pharmacol. Sci., 2002, 21, 52.
22. Passalacqua G, Bousquet J, Bachert C, Church MK, Bindslev-Jensen C, Nagy L, Szemere P, Davies RJ, Durham SR, Horak F, Kontou-Fili K, Malling H-J, van Cauwengberge P, Canonica GW. Allergy, 1991, 51, 666.
23. Young RC, Ganellin GR, Griffith R, Mitchell RC, Parsons ME, Saunders D, Sore NE. Eur. J. Med. Chem., 1993, 28, 201.
24. ter Laak AM, Tsai RS, Donné-op Den Kelder GM, Carrupt P-A, Testa B, Timmerman H. Eur. J. Pharm. Sci., 1994, 2, 373.
25. Reichel A, Siva J, Abbott NJ, Begley DJ. J. Physiol., 1999, 51, 58.
26. Cvethovic M, Leake B, Fronn MF, Wilkinson CR, Kim RB. Drug Metab. Dispos., 1999, 27, 866.
27. Chen C, Hanson E, Watson JW, Lee JS. Drug Metab. Dispos., 2003, 31, 312.
28. Chairungsrilerd N, Furukawa K-I, Ohta T, Nozoe S, Ohizumi Y. (1996), Eur. J. Pharmacol., 1996, 314, 351-356.
29. Bakker RA, Schoonus SB, Smit MJ, Timmerman H, Leurs R. Mol. Pharmacol., 2001, 60, 1133.
30. Bruijsters M, Pertz HH, Teunissen A, Bakker RA, Gkillard M, Chatelain P, Schumach W, Timmerman H, Leurs R. Eur. J. Pharmacol., 2004, 487, 55.
31. Holgate ST, Canonica GW, Simons FER, Tagliatatela M, Tharp M, Timmerman H, Yanai K. Clin. Exp. Allergy, 2003, 33, 1305.